Discover
ATOS
Atossa Therapeutics, Inc.
2.65
2 x 1.63
2 x 2.58
bid
ask
-
0.13
4.68%
2 @ 04:00 PM
2.67 +0.02 (0.70%)
| Ytd | -70.06% | |
| 1y | -83.17% |
2.54
day range
3.10
1.70
52 week range
15.45
| Open | 2.78 | Prev Close | 2.78 | Low | 2.54 | High | 3.10 | Mkt Cap | 26.45M |
| Vol | 226.01K | Avg Vol | 65.86K | EPS | -4.45 | P/E | N/A | Forward P/E | -3.81 |
| Beta | 1.23 | Short Ratio | 14.73 | Inst. Own | 28.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.42 | 200-d Avg | 4.37 | 1yr Est | 6.00 |
ATOS News
benzinga.com
Atossa Therapeutics Inks Stapled Contingent Value Rights Agreement With VStock Transfer; Atossa Decl
Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-sta
prnewswire.com
Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation
Board declares one stapled CVR for each share of Atossa common stock outstanding as of October 19, 2
benzinga.com
Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $25
Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics (NASDAQ:ATOS) with a Buy and